Pain News and Research

Latest Pain News and Research

Ulcerative colitis and Crohn’s disease treatments: an interview with Dr Parikh, vice president, general medicine, Takeda

Ulcerative colitis (UC) and Crohn’s disease (CD) are both relapsing and remitting chronic diseases of bowel inflammation. By that I mean they flare and physicians try to get the flare under control and try to induce remission. However, despite a number of treatments available, they tend to relapse.

From Takeda 3 Apr 2013

New study suggests targeting mental defeat feelings could prevent severe depression

A new study of Hong Kong chronic pain patients suggests that targeting feelings of mental defeat could prevent severe depression, anxiety and interference with daily activities.

3 Apr 2013

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.

3 Apr 2013

Ampio Pharmaceuticals receives FDA IND approval to start clinical trial of Ampion

Ampio Pharmaceuticals, Inc. today announced FDA acceptance of its IND and the treatment of the first fifteen (15) patients in its clinical trial using Ampion™ to treat osteoarthritis of the knee.

2 Apr 2013

Researchers examine effects of meditation on compassion, virtuous behavior

Scientists have mostly focused on the benefits of meditation for the brain and the body, but a recent study by Northeastern University's David DeSteno, published in Psychological Science, takes a look at what impacts meditation has on interpersonal harmony and compassion.

2 Apr 2013

Viewpoints: 'Big risks' of buying private insurance with Medicaid dollars; One month of sequestration

The Obama administration and Republican officials in several states are exploring ways to redirect federal money intended to expand Medicaid, the main public insurance program for the poor, and use it instead to buy private health insurance for Medicaid recipients.

2 Apr 2013

Halt Medical reveals initial commercialization results, additional launch plans for Acessa System

Halt Medical, Inc. announced today initial commercialization results for the Acessa System and additional launch plans.

1 Apr 2013

State roundup: NYC firms will be required to offer sick leave; Fla. government part-timers to get health coverage

New York is poised to mandate that companies with 15 or more employees provide paid time off for them when they are sick. A compromise agreement reached Thursday night resulted from a raw display of political muscle by a coalition of labor unions and liberal activists who overcame fierce objections from New York's business-minded mayor, Michael R. Bloomberg, and his allies in the corporate world (Barbaro and Grynbaum, 3/28).

30 Mar 2013

BioMed Central launches new journal BMC Sports Science, Medicine and Rehabilitation

Open access publisher BioMed Central is proud to announce the launch of BMC Sports Science, Medicine and Rehabilitation, another addition to the BMC-series portfolio.

30 Mar 2013

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

GE Healthcare today announced that it has submitted an application to amend its European Marketing Authorisation that will allow the company to manufacture Optison 0.19 mg/ml dispersion for injection within its own facility.

30 Mar 2013

FDA approves Teva's Quartette tablets for prevention of pregnancy

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy.

30 Mar 2013

Medicare reimbursement cuts threaten access to care

Physicians and patients alike are feeling the impact of Medicare reimbursement cuts that went into effect on January 1, 2013. With an additional 2% sequestration cut to roll out on April 1, it's likely that physicians who treat Medicare patients will be faced with difficult decisions as operating margins continue to shrink.

29 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

Children are vulnerable to eye injury while playing baseball, expert says

Baseball, America's favorite past time. From watching a child's first T-ball game to aspirations of playing in the Little League World Series, there is just something special about kids and baseball.

28 Mar 2013

Research findings could lead to improved treatment for neuropathic pain

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, says a key protein in Schwann cells performs a critical, perhaps overarching, role in regulating the recovery of peripheral nerves after injury.

28 Mar 2013

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences, Inc. today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated.

27 Mar 2013

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March 2013 the European Medicines Agency accepted its Marketing Authorisation Application submission for ospemifene for the treatment of vulvar and vaginal atrophy in post-menopausal women.

27 Mar 2013

New data reveals impact of opioid-related adverse events on length, cost of hospitalization after surgery

Pacira Pharmaceuticals, Inc. today announced data from a large-scale analysis of a national database of patients from 380 hospitals in the United States who underwent 319,898 inpatient surgeries and received opioids for postsurgical pain management.

27 Mar 2013

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive data for collagenase clostridium histolyticum or CCH which is being developed for the potential treatment, if approved by the U.S. Food and Drug Administration, of adult patients with adhesive capsulitis, commonly known as Frozen Shoulder syndrome.

26 Mar 2013

Pain News and Research

Latest Pain News and Research

Ulcerative colitis and Crohn’s disease treatments: an interview with Dr Parikh, vice president, general medicine, Takeda

New study suggests targeting mental defeat feelings could prevent severe depression

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

Ampio Pharmaceuticals receives FDA IND approval to start clinical trial of Ampion

Researchers examine effects of meditation on compassion, virtuous behavior

Viewpoints: 'Big risks' of buying private insurance with Medicaid dollars; One month of sequestration

Halt Medical reveals initial commercialization results, additional launch plans for Acessa System

State roundup: NYC firms will be required to offer sick leave; Fla. government part-timers to get health coverage

BioMed Central launches new journal BMC Sports Science, Medicine and Rehabilitation

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

FDA approves Teva's Quartette tablets for prevention of pregnancy

Medicare reimbursement cuts threaten access to care

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Children are vulnerable to eye injury while playing baseball, expert says

Research findings could lead to improved treatment for neuropathic pain

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

New data reveals impact of opioid-related adverse events on length, cost of hospitalization after surgery

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in